Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia

Human Immunology

Volumn 63, Issue 9, 2002, Pages 751-757

  De Rosa, Francesco G ^a,e   Pucillo, Leopoldo P ^b   Coviello, Rossella ^c   Pirro, Maria Rosaria ^c   Fiaschetti, Pamela ^c   Candela, Marco ^d   Gabrielli, Armando ^d   Laganà, Bruno ^c   Fiorilli, Massimo ^c   Casato, Milvia ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e Clinica Malattie Infettive   (Italy)

Author keywords

Anti GOR; HCV; Liver disease; Mixed cryoglobulinemia

Indexed keywords

ALANINE AMINOTRANSFERASE; AUTOANTIBODY;

ADULT; AGE; AGED; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOPATHOGENESIS; LIVER DISEASE; MALE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; ALANINE TRANSAMINASE; ANTIBODIES, ANTINUCLEAR; ANTIGENS; ANTIGENS, CD; AUTOANTIBODIES; AUTOIMMUNITY; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0036729427     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00423-8     Document Type: Article

References (26)

1. Biologic and clinical significance of cryoglobulins: A report of 86 cases
2. Type II cryoglobulinemia
3. Cryoglobulinaemias: A multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease
4. Hepatitis C virus in patients with cryoglobulinemia type II
5. Cryoglobulinemia and hepatitis C virus
6. Cryoglobulinemia and hepatitis C infection
7. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia
8. A role for hepatitis C virus infection in type II cryoglobulinemia
9. Cryoglobulinemia in chronic liver disease: Role of hepatitis C virus and liver damage
10. Incidence, character and clinical relevance of mixed cryoglobulinemia in patients with chronic hepatitis C virus infection
11. Interferon-a treatment of hepatitis C virus-associated mixed cryoglobulinemia
12. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia
13. Anti-GOR and anti-thyroid autoantibodies in patients with chronic hepatitis C
14. Type 2 autoimmune hepatitis and hepatitis C virus infection
15. An autoantibody cross-reactive to hepatitis C virus core and a host nuclear antigen
16. Characterization of anti-liver-kidney microsome antibody (anti-LKM-1) from hepatitis C virus-positive and -negative sera
17. In vitro secretion of anti-GOR protein and anti-hepatitis C virus antibodies in patients with chronic hepatitis C
18. Nonrheumatoid IgM in human hepatitis C virus-associated type II cryoglobulinemia recognize mimotopes of the CD4-like LAG- 3 protein
19. Patterns of immune responses to the host-encoded GOR and hepatitis C virus core-derived epitopes with relation to hepatitis C viremia, genotypes, and liver disease severity
20. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection
21. Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia
22. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection
23. Significance of antibody to the host cellular gene derived epitope GOR in chronic hepatitis C virus infection
24. Anti-GOR antibodies in anti-hepatitis C virus positive subjects with and without virus replication and liver disease
25. Chronic hepatitis C viral infection in patients with normal serum alanine aminotransferases
26. V(H) 1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen